Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment ...Middle East

Financing to advance lead asset RTX001, an engineered, pro-regenerative macrophage therapy with first-in-class potential for end-stage liver disease, into the Phase I/II EMERALD study Proceeds also strengthen manufacturing capabilities and support macrophage therapy pipeline growth in...

Hence then, the article about resolution therapeutics announces 63 5 million series b financing and chair appointment was published today ( Thursday 03/10/2024 - 09:37 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment )

Also on site :

• Man arrested on suspicion of fatal shooting in Huntington Beach
• Trump’s letter to Norway proves it: he’s lost his mind over the Nobel Peace Prize
• Trump refuses ‘to think purely of peace’